Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Nicholas Thompson who wrote (526)	4/18/1999 10:10:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

Oh, sorry--I put that third link there because it had a blurb about transcription factors, specifically the one aria has patents on. I Did not intend to point out the p53 stuff in terms of anything ariad is doing...guess I got off topic. I don't think Ariad is targeting cancers specifically...and I don't really have much of an opinion on Ligand...part of the reason I never got interested in that one is because it does actually seem to have a good following, and maybe because of that is not as cheap as many of the other biotech stocks discussed here on SI. There are several biotech value threads, you might want to look here if you want to shop for bargains--is Ligand a bargain, dunno...but it is not on the list. Message 8972146